Steffen Helmling
Corporate Officer/Principal at eTheRNA immunotherapies NV
Profile
Steffen joined Novalis LifeSciences as a senior advisor in 2023.
He is currently the Chief Business Officer (CBO) of Etherna, a leading technology innovator for the creation of RNA-based medicines.
Prior to Etherna, Steffen served as CBO of X-Chem, a global small molecule drug discovery company.
Steffen holds a Ph.D.
in biochemistry from the School of Biomedical Sciences at Tufts University in Boston, Massachusetts.
Steffen Helmling active positions
| Companies | Position | Start |
|---|---|---|
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Corporate Officer/Principal | 2023-06-07 |
Novalis Lifesciences LLC
 Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | Consultant / Advisor | 2022-12-31 |
Former positions of Steffen Helmling
| Companies | Position | End |
|---|---|---|
| NOXXON Pharma, Inc. | Corporate Officer/Principal | - |
| POLYMEDIX, INC. | Corporate Officer/Principal | - |
Training of Steffen Helmling
| Bowling Green State University | Graduate Degree |
| Tufts University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
| NOXXON Pharma, Inc. | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
Novalis Lifesciences LLC
Novalis Lifesciences LLC Investment ManagersFinance Novalis Lifesciences LLC (Novalis Lifesciences ) is a venture capital firm founded in 2013 by Marijn E. Dekkers. The firm is headquartered in Hampton, New Hampshire. | Finance |
- Stock Market
- Insiders
- Steffen Helmling
